Page last updated: 2024-10-22

anthralin and Hyperpigmentation

anthralin has been researched along with Hyperpigmentation in 2 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durdu, M1
Özcan, D1
Baba, M1
Seçkin, D1
Chavali, KH1
Dasari, H1

Other Studies

2 other studies available for anthralin and Hyperpigmentation

ArticleYear
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Anthralin; Apoptosis; CD4-CD8 R

2015
Dithranol: an unusual agent to produce artificial (false) bruise: a case report.
    The American journal of forensic medicine and pathology, 2012, Volume: 33, Issue:3

    Topics: Anthralin; Contusions; Deception; Humans; Hyperpigmentation; Irritants; Male; Ointments; Prisoners;

2012